111 Gross Margin 2018-2024 | YI

Current and historical gross margin for 111 (YI) over the last 10 years. The current gross profit margin for 111 as of September 30, 2024 is %.
111 Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $2.06B $0.12B 5.73%
2024-06-30 $2.05B $0.11B 5.57%
2024-03-31 $2.06B $0.11B 5.54%
2023-12-31 $2.11B $0.12B 5.65%
2023-09-30 $2.09B $0.12B 5.90%
2023-06-30 $2.05B $0.13B 6.09%
2023-03-31 $2.03B $0.13B 6.17%
2022-12-31 $1.96B $0.12B 6.18%
2022-09-30 $1.96B $0.12B 6.12%
2022-06-30 $2.01B $0.12B 5.88%
2022-03-31 $2.02B $0.11B 5.44%
2021-12-31 $1.95B $0.10B 5.03%
2021-09-30 $1.84B $0.08B 4.51%
2021-06-30 $1.67B $0.07B 4.19%
2021-03-31 $1.43B $0.06B 4.26%
2020-12-31 $1.26B $0.06B 4.37%
2020-09-30 $0.99B $0.04B 4.33%
2020-06-30 $0.80B $0.04B 4.62%
2020-03-31 $0.69B $0.03B 4.47%
2019-12-31 $0.57B $0.02B 4.23%
2019-09-30 $0.45B $0.02B 4.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.057B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Tempus AI (TEM) United States $10.232B 0.00
Hims & Hers Health (HIMS) United States $8.842B 224.83
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00